Jessica Cameron, OTR Occupational Therapist Medicare: Medicare Enrolled Practice Location: 106 Lincoln Place Ct, Belleville, IL 62221 Phone: 618-236-7588 Fax: 618-236-7589 |
Holly Keller, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1201 Hartman Ln, Belleville, IL 62221 Phone: 618-239-9282 Fax: 618-222-9304 |
Laurel Ranck Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 101 S Belt W, Belleville, IL 62220 Phone: 618-234-4741 |
Torey Hentis Occupational Therapist Medicare: Medicare Enrolled Practice Location: 101 S Belt W, Belleville, IL 62220 Phone: 618-277-7700 |
Tiffany Elizabeth Clifton, OTR L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4550 Memorial Dr, Medical Building #1 Ste 470, Belleville, IL 62226 Phone: 618-257-5249 Fax: 618-257-6805 |
Mrs. Heidi Dawn Hoskins, MS OTR Occupational Therapist - Neurorehabilitation Medicare: Not Enrolled in Medicare Practice Location: 4700 Memorial Drive, Moc 3, Suite 150, Belleville, IL 62226 Phone: 618-257-5758 Fax: 618-257-5298 |
Melissa Hickey, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2810 Frank Scott Pkwy W, Ste 824, Belleville, IL 62223 Phone: 618-234-9705 Fax: 618-257-0665 |
Melissa Parker, OCCUPATIONAL THERAPI Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2810 Frank Scott Pkwy W, Ste. 824, Belleville, IL 62223 Phone: 618-234-9705 Fax: 618-257-0665 |
Nicolle D Retzlaff, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2810 Frank Scott Pkwy W, Suite 824, Belleville, IL 62223 Phone: 618-234-9705 Fax: 618-257-0665 |
Regina E Peterman Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 101 S Belt W, Belleville, IL 62220 Phone: 618-234-4741 |
Kristin M Geis, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2422 Ben Hogan Dr, Belleville, IL 62220 Phone: 618-416-1915 |
Sharon Kay Danner Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2810 Frank Scott Pkwy W, Suite 824, Belleville, IL 62223 Phone: 618-234-9705 Fax: 618-257-0665 |
Kelly J Mincemeyer, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2810 Frank Scott Pkwy W, Ste.824, Belleville, IL 62223 Phone: 618-234-9705 Fax: 618-257-0665 |
Stacy Arnold, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2810 Frank Scott Pkwy W, Ste 824, Belleville, IL 62223 Phone: 618-234-9705 Fax: 618-257-0665 |
Stacie L Walter, O.T. Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 2810 Frank Scott Pkwy W, Suite 824, Belleville, IL 62223 Phone: 618-234-9705 Fax: 618-257-0665 |
Lucy Karst Kreh, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4500 Memorial Dr, Belleville, IL 62226 Phone: 618-257-5250 |
Megan T Shah, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2810 Frank Scott Pkwy W, Ste 824, Belleville, IL 62223 Phone: 618-234-9705 Fax: 618-257-0665 |
News Archive
Proteostasis Therapeutics announced today that modulating a key Proteostasis Network (PN) pathway may offer a novel approach to Alzheimer's disease, a finding that was published in the journal Cell by its scientific founders Andrew Dillin, Ph.D., and Jeffery Kelly, Ph.D. The publication describes how regulation of an aggregase pathway reduced the neurodegenerative effects of beta amyloid aggregates that are a hallmark of the disease.
People with high levels of "good cholesterol," HDL-C, tend to have fewer heart attacks, but HDL-C may offer little protection to people who take statins to lower harmful LDL cholesterol, researchers reported July 21. At Brigham and Women's Hospital in Boston, Dr. Paul Ridker and colleagues analyzed a large study of healthy people who took the statin CRESTOR® (rosuvastatin calcium) to prevent heart attacks. They found that in this group, having high HDL-C was a bad predictor of heart attack risk.
Today, Pisgah Labs, Inc. received a Notice of Allowance from the United States Patent and Trademark office for an important new technology patent addressing global stability problems of thyroid hormone drugs.
The Committee for Medicinal Products for Human Use (CHMP) of the The European Medicines Agency (EMA) has recommended today to lift the EU-wide suspension of the marketing authorizations of both octagam® and octagam®10% which has been in place since September 2010, subject to certain conditions.
The study reveals a detailed epigenetic mechanism for how interleukin-1-beta, a common cytokine that helps fight infections during inflammation, plays a critical role in cancer metastasis.
› Verified 5 days ago